X-Pressure is developing a medical device that measures cerebrospinal fluid pressure using advanced mechanical biomarkers to enhance the diagnosis of brain diseases. This technology provides clinicians with real-time data and decision-support algorithms, improving treatment outcomes in neurological care.
Funding
$4.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing and managing brain diseases often requires monitoring cerebrospinal fluid pressure (CSF), which traditionally involves complex procedures and specialized equipment. Current methods may lack real-time data and decision support, potentially delaying accurate diagnoses and optimized treatment plans.
Solution
X-Pressure is developing XP One, a medical device designed for real-time bedside assessment of cerebrospinal fluid dynamics. The device aims to simplify and standardize CSF infusion tests, providing clinicians with precise measurements of CSF outflow resistance. By leveraging medical-grade AI and cloud technology, XP One analyzes data against a large dataset of clinical cases to identify clinically significant thresholds. This enables more confident detection of normal pressure hydrocephalus (NPH) and supports shunt management decisions, ultimately improving treatment outcomes in neurological care.
Target Audience
The primary target audience includes neurologists and other clinicians involved in the diagnosis and management of brain diseases, particularly normal pressure hydrocephalus.
Features
- Real-time monitoring of cerebrospinal fluid pressure at the bedside
- Standardized CSF infusion tests for consistent and reliable data collection
- Medical-grade AI algorithms for identifying clinically significant thresholds
- Cloud-based platform for data storage, analysis, and reporting
- Decision-support algorithms based on 25 years of multicenter datasets